PreprintArticleVersion 1Preserved in Portico This version is not peer-reviewed
Usefulness of Novel Atherogenic Lipid Indices for The Evaluation of Metabolic Status Leading to Coronary Heart Disease in A Real-World Survey of The Japanese Population
Matsunaga, I.; Ando, M.; Tsubakimoto, Y.; Nagasawa, M.; Kurumi, Y. Usefulness of Novel Atherogenic Lipid Indices for the Evaluation of Metabolic Status Leading to Coronary Heart Disease in a Real-World Survey of the Japanese Population. Healthcare2022, 10, 747.
Matsunaga, I.; Ando, M.; Tsubakimoto, Y.; Nagasawa, M.; Kurumi, Y. Usefulness of Novel Atherogenic Lipid Indices for the Evaluation of Metabolic Status Leading to Coronary Heart Disease in a Real-World Survey of the Japanese Population. Healthcare 2022, 10, 747.
Matsunaga, I.; Ando, M.; Tsubakimoto, Y.; Nagasawa, M.; Kurumi, Y. Usefulness of Novel Atherogenic Lipid Indices for the Evaluation of Metabolic Status Leading to Coronary Heart Disease in a Real-World Survey of the Japanese Population. Healthcare2022, 10, 747.
Matsunaga, I.; Ando, M.; Tsubakimoto, Y.; Nagasawa, M.; Kurumi, Y. Usefulness of Novel Atherogenic Lipid Indices for the Evaluation of Metabolic Status Leading to Coronary Heart Disease in a Real-World Survey of the Japanese Population. Healthcare 2022, 10, 747.
Abstract
We evaluated the usefulness of the novel cholesterol-triglyceride subgroup (CTS) indices that potentially reflect the metabolic status regarding risk of coronary heart disease (CHD) using a retrospective longitudinal study of the Japanese general population. We recruited 12,373 individuals from the annual users of our healthcare center. Among them, the first onset of CHD was recorded in 131 individuals between April, 2014 and March, 2020. The multivariate Cox proportional hazards regression analyses for all normalized lipid indices revealed that the CTSqnt index showed a comparable hazard ratio for the CHD outcome to non-high-density lipoprotein cholesterol (nonHDL-c) and triglycerides. The HR of the CTSqlt index was significantly lower than for CTSqnt, but still comparable to that for low-density lipoprotein cholesterol (LDL-c). In comparison with the other indices, CTSqlt is more sensitive to risk increment while the index value increases. Linear regression analyses for the CTS indices and previously known lipid indices suggest that the CTSqnt and CTSqlt indices reflect the quantity of atherogenic lipoproteins and size of smaller and denser LDLs, respectively. Furthermore, the CTSqnt/HDL-c index can be used as a comprehensive risk indicator that may represent the status of lipid metabolism determined by the CTSqlt and CTSqnt indices and thus may be useful for screening. The CTS indices can be used to evaluate the metabolic status of individuals, which may increase the risk of future CHD.
Keywords
Atherogenesis; metabolic status; lipid index; coronary heart disease; medical check-up
Subject
Medicine and Pharmacology, Cardiac and Cardiovascular Systems
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
